Astrana Net Invested Capital vs Long Term Debt Analysis

ASTH Stock   43.25  0.39  0.91%   
Astrana Health financial indicator trend analysis is way more than just evaluating Astrana Health prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Astrana Health is a good investment. Please check the relationship between Astrana Health Net Invested Capital and its Long Term Debt accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Astrana Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.

Net Invested Capital vs Long Term Debt

Net Invested Capital vs Long Term Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Astrana Health Net Invested Capital account and Long Term Debt. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Astrana Health's Net Invested Capital and Long Term Debt is 0.92. Overlapping area represents the amount of variation of Net Invested Capital that can explain the historical movement of Long Term Debt in the same time period over historical financial statements of Astrana Health, assuming nothing else is changed. The correlation between historical values of Astrana Health's Net Invested Capital and Long Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Invested Capital of Astrana Health are associated (or correlated) with its Long Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Long Term Debt has no effect on the direction of Net Invested Capital i.e., Astrana Health's Net Invested Capital and Long Term Debt go up and down completely randomly.

Correlation Coefficient

0.92
Relationship DirectionPositive 
Relationship StrengthVery Strong

Net Invested Capital

The total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents.

Long Term Debt

Long-term debt is a debt that Astrana Health has held for over one year. Long-term debt appears on Astrana Health balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Astrana Health balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.
Most indicators from Astrana Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Astrana Health current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Astrana Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.The Astrana Health's current Selling General Administrative is estimated to increase to about 118.2 M, while Tax Provision is projected to decrease to under 22.8 M.
 2021 2022 2023 2024 (projected)
Cost Of Revenue596.1M944.7M1.2B1.2B
Total Revenue773.9M1.1B1.4B1.5B

Astrana Health fundamental ratios Correlations

0.920.940.940.120.860.550.960.990.640.770.940.980.960.990.480.90.730.770.990.650.94-0.910.970.870.87
0.920.990.970.070.950.540.960.920.550.720.890.960.950.940.430.880.860.620.890.840.96-0.760.880.820.94
0.940.990.960.10.920.590.960.940.560.720.910.960.960.950.430.890.870.610.910.830.95-0.770.90.80.92
0.940.970.960.050.970.450.990.950.60.740.920.990.960.970.480.90.780.740.90.790.96-0.810.940.910.96
0.120.070.10.050.09-0.310.010.180.030.030.390.020.290.20.050.470.44-0.080.050.260.22-0.220.18-0.02-0.07
0.860.950.920.970.090.320.950.880.580.70.880.930.920.910.490.880.790.670.80.840.94-0.720.880.870.95
0.550.540.590.45-0.310.320.520.50.290.380.380.520.470.460.150.310.40.340.620.260.36-0.260.370.380.38
0.960.960.960.990.010.950.520.970.610.740.921.00.950.970.490.890.750.780.940.750.94-0.820.950.920.95
0.990.920.940.950.180.880.50.970.630.750.970.980.981.00.490.940.760.780.970.680.95-0.890.980.890.87
0.640.550.560.60.030.580.290.610.630.510.590.610.590.620.720.550.380.570.640.370.57-0.60.620.580.57
0.770.720.720.740.030.70.380.740.750.510.70.750.730.750.310.670.530.570.760.50.73-0.720.750.660.71
0.940.890.910.920.390.880.380.920.970.590.70.920.990.970.480.990.820.710.90.730.95-0.860.950.840.81
0.980.960.960.990.020.930.521.00.980.610.750.920.960.980.480.890.750.770.950.740.95-0.850.960.910.94
0.960.950.960.960.290.920.470.950.980.590.730.990.960.990.470.980.860.690.930.780.97-0.850.950.850.87
0.990.940.950.970.20.910.460.971.00.620.750.970.980.990.490.950.780.760.960.710.97-0.90.980.880.89
0.480.430.430.480.050.490.150.490.490.720.310.480.480.470.490.460.280.460.470.320.45-0.460.490.480.46
0.90.880.890.90.470.880.310.890.940.550.670.990.890.980.950.460.870.650.850.780.94-0.830.930.80.81
0.730.860.870.780.440.790.40.750.760.380.530.820.750.860.780.280.870.280.670.930.81-0.570.730.540.74
0.770.620.610.74-0.080.670.340.780.780.570.570.710.770.690.760.460.650.280.760.240.68-0.710.740.940.67
0.990.890.910.90.050.80.620.940.970.640.760.90.950.930.960.470.850.670.760.580.89-0.90.940.840.84
0.650.840.830.790.260.840.260.750.680.370.50.730.740.780.710.320.780.930.240.580.76-0.50.70.530.81
0.940.960.950.960.220.940.360.940.950.570.730.950.950.970.970.450.940.810.680.890.76-0.870.930.850.91
-0.91-0.76-0.77-0.81-0.22-0.72-0.26-0.82-0.89-0.6-0.72-0.86-0.85-0.85-0.9-0.46-0.83-0.57-0.71-0.9-0.5-0.87-0.92-0.76-0.78
0.970.880.90.940.180.880.370.950.980.620.750.950.960.950.980.490.930.730.740.940.70.93-0.920.850.88
0.870.820.80.91-0.020.870.380.920.890.580.660.840.910.850.880.480.80.540.940.840.530.85-0.760.850.85
0.870.940.920.96-0.070.950.380.950.870.570.710.810.940.870.890.460.810.740.670.840.810.91-0.780.880.85
Click cells to compare fundamentals

Astrana Health Account Relationship Matchups

Astrana Health fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets728.7M817.5M867.4M966.2M933.4M980.0M
Other Current Liab77.0M74.1M88.5M128.5M184.1M193.3M
Total Current Liabilities105.4M115.0M114.7M148.6M218.7M229.6M
Total Stockholder Equity191.5M330.8M448.2M542.6M614.2M644.9M
Net Debt153.3M67.1M(32.1M)(58.7M)27.2M28.6M
Retained Earnings31.9M69.8M137.2M182.4M243.1M255.3M
Accounts Payable6.9M9.6M5.5M10.5M9.1M9.5M
Cash103.3M193.5M233.1M288.0M293.8M308.5M
Cash And Short Term Investments219.8M261.2M286.5M293.6M296.3M311.1M
Common Stock Total Equity35.9K42K45K47K54.1K30.0K
Common Stock Shares Outstanding36.4M37.4M45.4M45.6M47.1M49.4M
Liabilities And Stockholders Equity728.7M817.5M867.4M966.2M933.4M980.0M
Non Current Liabilities Total262.2M257.3M242M259.1M303.9M319.1M
Other Stockholder Equity159.6M261.0M310.9M360.1M371.0M389.6M
Total Liab367.7M372.3M356.7M407.7M522.6M548.7M
Total Current Assets329.1M338.6M404.5M428.1M461.5M484.6M
Common Stock35.9K42K45K47K54.1K33.4K
Short Long Term Debt Total256.6M260.6M201.0M229.4M321.0M337.1M
Short Term Debt12.6M14.2M3.9M4.8M24.8M26.0M
Property Plant And Equipment Net26.4M48.5M68.6M129.0M44.6M23.8M
Non Current Assets Total399.6M478.9M462.9M538.1M471.9M495.4M
Non Currrent Assets Other1.7M19.4M5.9M4.6M44.6M46.9M
Net Receivables99.0M60.6M99.3M119.7M147.8M155.1M
Other Current Assets10.3M16.8M18.6M14.8M17.5M18.3M
Property Plant And Equipment Gross26.4M48.5M68.6M129.0M67.4M70.8M
Net Tangible Assets18.8M119.0M118.7M214.0M246.1M258.4M
Current Deferred Revenue8.9M13.0M16.8M531K744K706.8K
Noncontrolling Interest In Consolidated Entity786.2K87K5.9M2.2M2.5M1.8M
Other Assets2.4M55.3M6.5M6.1M22.1M12.9M
Long Term Debt232.2M230.2M182.9M203.4M258.9M271.9M
Good Will238.5M239.1M246.4M269.1M278.8M139.8M
Retained Earnings Total Equity31.9M69.8M143.6M192.7M221.6M232.7M
Short Term Investments116.5M67.7M53.4M5.6M2.5M2.4M
Long Term Debt Total232.2M230.2M182.9M203.4M233.9M245.6M
Capital Surpluse159.6M261.0M310.9M360.1M414.1M434.8M
Deferred Long Term Liab18.3M11.0M9.1M3.0M3.5M6.8M
Intangible Assets103.0M87.0M82.8M76.9M71.6M56.4M

Currently Active Assets on Macroaxis

When determining whether Astrana Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Astrana Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Astrana Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Astrana Health Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Astrana Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.
You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Astrana Health. If investors know Astrana will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Astrana Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.30)
Earnings Share
1.3
Revenue Per Share
36.415
Quarterly Revenue Growth
0.375
Return On Assets
0.0449
The market value of Astrana Health is measured differently than its book value, which is the value of Astrana that is recorded on the company's balance sheet. Investors also form their own opinion of Astrana Health's value that differs from its market value or its book value, called intrinsic value, which is Astrana Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Astrana Health's market value can be influenced by many factors that don't directly affect Astrana Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Astrana Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Astrana Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Astrana Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.